SMK-1, a novel, conserved nuclear activator of DAF-16/FOXO tumor suppressor
Description: Cancer and aging share many common biology. As a result, many anti-aging compounds (e.g., rapamycin, metformin, and probably resveratrol) also delay the onset of various cancers. Transcription factors act like “genetic switches” by turning on and off the transcription of genetic information from DNA to messenger RNA. Not surprisingly, malfunction of many transcription factors plays key roles in the process of aging and cancer development. FOXO family transcription factors are best studied to play evolutionarily conserved functions in aging from worms to humans. Mutations in FOXO1 are directly responsible for rhabdomyosarcomas while FOXO3 and FOXO4 play critical roles in acute myeloid leukaemias. Therefore, a better understanding of FOXO transcription factors biology can not only improve our knowledge on the regulation of transcription factors in general, but also provide invaluable information on developing these transcription factors as potential targets for cancer therapy.
The nematode C. elegans is arguably the most common genetic model organism to study aging due to its short generation period and lifespan as well as facile genetics. Meanwhile, multiple cancer models have been developed and verified in C. elegans to study conserved signaling pathways involved in cancer development. Most importantly, many aging- and cancer-related signaling pathways are evolutionarily conserved from C. elegans to humans. Therefore, the genetic dissection of aging in C. elegans can often provide very useful information on similar processes in other species. For example, insulin signaling pathway was first reported in C. elegans to modulate aging and later confirmed in mammals. Importantly, most long-lived worms and mice are more resistant to various cellular stressors and have delayed occurrence of various deadly diseases including cancers.
DAF-16, the sole orthologue of FOXO family transcription factors in C. elegans, plays a central role in animal aging, stress response, and tumor suppression. In this proposal, our short term goal is to identify novel regulation of DAF-16/FOXO in the process of aging and cellular stress response. In the long term, we aim to build on the knowledge we gain from the proposed C. elegans studies to investigate the similar regulations of mammalian FOXO transcription factors in stress response and tumor suppression. Toward these goals, we have identified a previously little studied protein phosphatase which can specifically remove phosphates from FOXO transcription factor and enhance cellular stress resistance, delay aging, and suppress tumor growth. In this proposal, we will investigate the genetic and biochemical mechanisms by which this protein phosphatase can enhance FOXO transcription activity and promote longevity, stress resistance, and tumor suppression. These proposed studies will lead to a better understanding of various cancers involving FOXO transcription factors and protein phosphatases.
Funder: American Cancer Society
Amount: $792,000
Funding type: award
Start date: 2018-01-01
End date: 2023-12-31
Investigator: Rui Xiao (lead)
Institution: University of Florida
Subfield: Molecular Biology
Domain: Life Sciences
Funded outputs count: 8
Funder award ID: RSG-17-171-01-DMC
OpenAlex ID: G5036187902
